PALO ALTO, Calif., Sept. 21, 2017 /PRNewswire/ -- Varian Medical
Systems (NYSE: VAR) today announced a patient at Penn Medicine,
with head & neck cancer, became the first person in the world
to be treated on Varian's Halcyon™ system, its new
platform for cancer treatment. Halcyon is well suited to handle the
majority of cancer patients, offering advanced treatments for
prostate, breast, head & neck, and many other forms of
cancer.
The treatment for this patient at Penn Medicine was a complex
case that involved the delivery of nine fields. The total patient
time in the treatment room, including set-up, imaging, three
minutes of beam time and patient discharge, was only 13 minutes*.
Typically, a treatment like this using other radiation technology
can take 10 minutes of beam time and 20 minutes total treatment
time.
Halcyon is an advanced system that is more comfortable for the
patient while delivering ease of use for healthcare providers,
accelerated installation timeframes, expedited commissioning,
simplified training, and automated treatment.
"The first patient treatment is a major milestone for the
Halcyon system," said Kolleen
Kennedy, president of Varian's Oncology Systems business.
"Working closely with leading institutions like Penn Medicine,
helped shape the human-centered design focus of Halcyon and our
ability to deliver a system that simplifies and enhances virtually
every aspect of image-guided volumetric intensity modulated
radiotherapy (IMRT). We are excited to see treatments commencing
and continuing our efforts of advancing cost-effective cancer care
worldwide."
"We are proud to have delivered the world's first Halcyon
treatment, which contributes to our ongoing mission to provide
patients the widest and most advanced array of cancer treatment
options," said James Metz, MD, chair of Radiation Oncology at
Penn Medicine. "This platform combines reduced treatment time with
simplified operation, and for some diseases, it even lets us be
more precise with the radiation we're delivering."
For more information on Halcyon, visit
www.varian.com/halcyon
About Varian Medical Systems
Varian Medical Systems
focuses energy on saving lives and is the world's leading
manufacturer of medical devices and software for treating and
managing cancer. Headquartered in Palo
Alto, California, Varian employs approximately 6,600 people
around the world. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
*Results may vary
Press Contact
Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/varian-announces-penn-medicine-treats-worlds-first-patient-on-halcyon-system-300523442.html
SOURCE Varian Medical Systems